6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.
If financial markets any indication, a lot must be expected from Fed Chair Powell Thursday morning. Plus, two guys to never bet against.
Expectations are high for what's likely to be a news-making speech by the Fed Chair. Here's why it matters to investors.
The amateurs won. Is that really possible? It happened.
The extreme disconnect between breadth and the indices is unlikely to continue for very long.
Psychedelic companies hoping to capitalize on a surging interest in psilocybin treatments have been limited to one source for research grade psilocybin. Until now.
Sarge chooses Disneyland over Vegas and answers your questions, including who's next to a $2 trillion market cap after Apple.
Seven consequences of what Salesforce and Marc Benioff, the exec most close to Covid, announced Wednesday.
Investment advisors overly bullish sentiment intensifies.
The pandemic has reinforced the value of a safe home with a little space to work, exercise, and relax at a safe distance from neighbors.